The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells (Q28678816)

2

1 reference

6 February 2017

J. M. Green

3

1 reference

6 February 2017

L. Foy

4

1 reference

6 February 2017

H. P. Fell

5

1 reference

6 February 2017

K. Zhang

Journal of Biological Chemistry

6

1 reference

6 February 2017

language of work or name

English

0 references

publication date

29 November 1996

1 reference

6 February 2017

1 reference

6 February 2017

271

1 reference

6 February 2017

30897–30903

1 reference

6 February 2017

48

1 reference

6 February 2017

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

The neu oncogene encodes an epidermal growth factor receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

21 January 2018

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Receptors for epidermal growth factor and other polypeptide mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Identification of heregulin, a specific activator of p185erbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Inositol phosphates and cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

The molecular heterogeneity of protein kinase C and its implications for cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

HER4 expression correlates with cytotoxicity directed by a heregulin-toxin fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Growth factor signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897

The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30897